세계의 락토페린 제품 시장(2024-2028년)

The lactoferrin products market is forecasted to grow by USD 4.89 bn during 2023-2028, accelerating at a CAGR of 16.3% during the forecast period. The report on the lactoferrin products market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increasing number of working women and nuclear families, an increase in a number of mothers with lower milk supply, and accessible distribution channels to consumers.

Technavio's lactoferrin products market is segmented as below:

By Application

• Infant formula
• Sports and functional Foods
• Food and beverages
• Others

By Usage

• Iron absorption
• Intestinal flora protection
• Anti-inflammatory
• Antibacterial and others

By Geographical Landscape

• APAC
• Europe
• North America
• South America
• Middle East and Africa

This study identifies the rising demand for online retail as one of the prime reasons driving the lactoferrin products market growth during the next few years. Also, increasing awareness about lactose-free products and strategic initiatives by vendors in the global lactoferrin products market will lead to sizable demand in the market.

The report on the lactoferrin products market covers the following areas:

• Lactoferrin products market sizing
• Lactoferrin products market forecast
• Lactoferrin products market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading lactoferrin products market vendors that include Advanced Orthomolecular Research Inc., Bega Cheese Ltd., Blackmores Ltd., Cure Nutraceutical PVT. LTD., Fonterra Cooperative Group Ltd., Glanbia plc, INGREDIA SA, Inner Mongolia Yili Industrial Group Co. Ltd., Jarrow Formulas Inc., Lactoferrin Co., Life Extension Foundation Buyers Club Inc., Morinaga Milk Industry Co. Ltd., Morishita Jintan Co. Ltd., Noumi Ltd., Oskia Skincare Ltd., Royal FrieslandCampina NV, Saraya Co. Ltd., Savencia SA, TurtleTree, US CLINICALS, ZIEXA HEALTHCARE, and Zifam Pinnacle Pty. Ltd.. Also, the lactoferrin products market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Usage
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global lactoferrin products market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global lactoferrin products market 2018 - 2022 ($ billion)
• 4.2 Application Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
• 4.3 Usage Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Usage Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 30: Chart on Application - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
• 6.2 Comparison by Application
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application
• 6.3 Infant formula - Market size and forecast 2023-2028
• Exhibit 34: Chart on Infant formula - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Infant formula - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Infant formula - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Infant formula - Year-over-year growth 2023-2028 (%)
• 6.4 Sports and functional foods - Market size and forecast 2023-2028
• Exhibit 38: Chart on Sports and functional foods - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Sports and functional foods - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Sports and functional foods - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Sports and functional foods - Year-over-year growth 2023-2028 (%)
• 6.5 Food and beverages - Market size and forecast 2023-2028
• Exhibit 42: Chart on Food and beverages - Market size and forecast 2023-2028 ($ billion)
• Exhibit 43: Data Table on Food and beverages - Market size and forecast 2023-2028 ($ billion)
• Exhibit 44: Chart on Food and beverages - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Food and beverages - Year-over-year growth 2023-2028 (%)
• 6.6 Others - Market size and forecast 2023-2028
• Exhibit 46: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 47: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 48: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.7 Market opportunity by Application
• Exhibit 50: Market opportunity by Application ($ billion)
• Exhibit 51: Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by Usage

• 7.1 Market segments
• Exhibit 52: Chart on Usage - Market share 2023-2028 (%)
• Exhibit 53: Data Table on Usage - Market share 2023-2028 (%)
• 7.2 Comparison by Usage
• Exhibit 54: Chart on Comparison by Usage
• Exhibit 55: Data Table on Comparison by Usage
• 7.3 Iron absorption - Market size and forecast 2023-2028
• Exhibit 56: Chart on Iron absorption - Market size and forecast 2023-2028 ($ billion)
• Exhibit 57: Data Table on Iron absorption - Market size and forecast 2023-2028 ($ billion)
• Exhibit 58: Chart on Iron absorption - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Iron absorption - Year-over-year growth 2023-2028 (%)
• 7.4 Intestinal flora protection - Market size and forecast 2023-2028
• Exhibit 60: Chart on Intestinal flora protection - Market size and forecast 2023-2028 ($ billion)
• Exhibit 61: Data Table on Intestinal flora protection - Market size and forecast 2023-2028 ($ billion)
• Exhibit 62: Chart on Intestinal flora protection - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Intestinal flora protection - Year-over-year growth 2023-2028 (%)
• 7.5 Anti-inflammatory - Market size and forecast 2023-2028
• Exhibit 64: Chart on Anti-inflammatory - Market size and forecast 2023-2028 ($ billion)
• Exhibit 65: Data Table on Anti-inflammatory - Market size and forecast 2023-2028 ($ billion)
• Exhibit 66: Chart on Anti-inflammatory - Year-over-year growth 2023-2028 (%)
• Exhibit 67: Data Table on Anti-inflammatory - Year-over-year growth 2023-2028 (%)
• 7.6 Antibacterial and others - Market size and forecast 2023-2028
• Exhibit 68: Chart on Antibacterial and others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 69: Data Table on Antibacterial and others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 70: Chart on Antibacterial and others - Year-over-year growth 2023-2028 (%)
• Exhibit 71: Data Table on Antibacterial and others - Year-over-year growth 2023-2028 (%)
• 7.7 Market opportunity by Usage
• Exhibit 72: Market opportunity by Usage ($ billion)
• Exhibit 73: Data Table on Market opportunity by Usage ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 75: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 77: Chart on Geographic comparison
• Exhibit 78: Data Table on Geographic comparison
• 9.3 APAC - Market size and forecast 2023-2028
• Exhibit 79: Chart on APAC - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on APAC - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on APAC - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on APAC - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 North America - Market size and forecast 2023-2028
• Exhibit 87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.6 South America - Market size and forecast 2023-2028
• Exhibit 91: Chart on South America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on South America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on South America - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on South America - Year-over-year growth 2023-2028 (%)
• 9.7 Middle East and Africa - Market size and forecast 2023-2028
• Exhibit 95: Chart on Middle East and Africa - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on Middle East and Africa - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on Middle East and Africa - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Middle East and Africa - Year-over-year growth 2023-2028 (%)
• 9.8 China - Market size and forecast 2023-2028
• Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.9 Australia - Market size and forecast 2023-2028
• Exhibit 103: Chart on Australia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 104: Data Table on Australia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 105: Chart on Australia - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on Australia - Year-over-year growth 2023-2028 (%)
• 9.10 US - Market size and forecast 2023-2028
• Exhibit 107: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 108: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 109: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 110: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 111: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 112: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 113: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 114: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Germany - Market size and forecast 2023-2028
• Exhibit 115: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 116: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 117: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 118: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.13 Market opportunity By Geographical Landscape
• Exhibit 119: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 120: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 121: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 122: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 123: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 124: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 125: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 126: Matrix on vendor position and classification
• 12.3 Advanced Orthomolecular Research Inc.
• Exhibit 127: Advanced Orthomolecular Research Inc. - Overview
• Exhibit 128: Advanced Orthomolecular Research Inc. - Product / Service
• Exhibit 129: Advanced Orthomolecular Research Inc. - Key offerings
• 12.4 Bega Cheese Ltd.
• Exhibit 130: Bega Cheese Ltd. - Overview
• Exhibit 131: Bega Cheese Ltd. - Business segments
• Exhibit 132: Bega Cheese Ltd. - Key offerings
• Exhibit 133: Bega Cheese Ltd. - Segment focus
• 12.5 Blackmores Ltd.
• Exhibit 134: Blackmores Ltd. - Overview
• Exhibit 135: Blackmores Ltd. - Business segments
• Exhibit 136: Blackmores Ltd. - Key offerings
• Exhibit 137: Blackmores Ltd. - Segment focus
• 12.6 Cure Nutraceutical PVT. LTD.
• Exhibit 138: Cure Nutraceutical PVT. LTD. - Overview
• Exhibit 139: Cure Nutraceutical PVT. LTD. - Product / Service
• Exhibit 140: Cure Nutraceutical PVT. LTD. - Key offerings
• 12.7 Fonterra Cooperative Group Ltd.
• Exhibit 141: Fonterra Cooperative Group Ltd. - Overview
• Exhibit 142: Fonterra Cooperative Group Ltd. - Business segments
• Exhibit 143: Fonterra Cooperative Group Ltd. - Key offerings
• Exhibit 144: Fonterra Cooperative Group Ltd. - Segment focus
• 12.8 Glanbia plc
• Exhibit 145: Glanbia plc - Overview
• Exhibit 146: Glanbia plc - Business segments
• Exhibit 147: Glanbia plc - Key offerings
• Exhibit 148: Glanbia plc - Segment focus
• 12.9 INGREDIA SA
• Exhibit 149: INGREDIA SA - Overview
• Exhibit 150: INGREDIA SA - Product / Service
• Exhibit 151: INGREDIA SA - Key offerings
• 12.10 Jarrow Formulas Inc.
• Exhibit 152: Jarrow Formulas Inc. - Overview
• Exhibit 153: Jarrow Formulas Inc. - Product / Service
• Exhibit 154: Jarrow Formulas Inc. - Key offerings
• 12.11 Lactoferrin Co.
• Exhibit 155: Lactoferrin Co. - Overview
• Exhibit 156: Lactoferrin Co. - Product / Service
• Exhibit 157: Lactoferrin Co. - Key offerings
• 12.12 Noumi Ltd.
• Exhibit 158: Noumi Ltd. - Overview
• Exhibit 159: Noumi Ltd. - Business segments
• Exhibit 160: Noumi Ltd. - Key offerings
• Exhibit 161: Noumi Ltd. - Segment focus
• 12.13 Oskia Skincare Ltd.
• Exhibit 162: Oskia Skincare Ltd. - Overview
• Exhibit 163: Oskia Skincare Ltd. - Product / Service
• Exhibit 164: Oskia Skincare Ltd. - Key offerings
• 12.14 Royal FrieslandCampina NV
• Exhibit 165: Royal FrieslandCampina NV - Overview
• Exhibit 166: Royal FrieslandCampina NV - Business segments
• Exhibit 167: Royal FrieslandCampina NV - Key news
• Exhibit 168: Royal FrieslandCampina NV - Key offerings
• Exhibit 169: Royal FrieslandCampina NV - Segment focus
• 12.15 Savencia SA
• Exhibit 170: Savencia SA - Overview
• Exhibit 171: Savencia SA - Business segments
• Exhibit 172: Savencia SA - Key offerings
• Exhibit 173: Savencia SA - Segment focus
• 12.16 US CLINICALS
• Exhibit 174: US CLINICALS - Overview
• Exhibit 175: US CLINICALS - Product / Service
• Exhibit 176: US CLINICALS - Key offerings
• 12.17 Zifam Pinnacle Pty. Ltd.
• Exhibit 177: Zifam Pinnacle Pty. Ltd. - Overview
• Exhibit 178: Zifam Pinnacle Pty. Ltd. - Product / Service
• Exhibit 179: Zifam Pinnacle Pty. Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 180: Inclusions checklist
• Exhibit 181: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 182: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 183: Research methodology
• Exhibit 184: Validation techniques employed for market sizing
• Exhibit 185: Information sources
• 13.5 List of abbreviations
• Exhibit 186: List of abbreviations